These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7004349)

  • 1. Interaction between aminoglycoside uptake and ribosomal resistance mutations.
    Ahmad MH; Rechenmacher A; Böck A
    Antimicrob Agents Chemother; 1980 Nov; 18(5):798-806. PubMed ID: 7004349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fortimicins with other aminoglycosides and effects on bacterial ribosome and protein synthesis.
    Moreau N; Jaxel C; Le Goffic F
    Antimicrob Agents Chemother; 1984 Dec; 26(6):857-62. PubMed ID: 6395800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of erythromycin to the 50S ribosomal subunit is affected by alterations in the 30S ribosomal subunit.
    Saltzman L; Apirion D
    Mol Gen Genet; 1976 Feb; 143(3):301-6. PubMed ID: 765762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosomal resistance in the gentamicin producer organism Micromonospora purpurea.
    Piendl W; Böck A
    Antimicrob Agents Chemother; 1982 Aug; 22(2):231-6. PubMed ID: 6927285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial ribosomes with two ambiguity mutations: effects of translational fidelity, on the response to aminoglycosides and on the rate of protein synthesis.
    Piepersberg W; Noseda V; Böck A
    Mol Gen Genet; 1979 Mar; 171(1):23-34. PubMed ID: 108518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside resistance with homogeneous and heterogeneous populations of antibiotic-resistant ribosomes.
    Recht MI; Puglisi JD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2414-9. PubMed ID: 11502507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial uptake of habekacin, a novel aminoglycoside antibiotic.
    Matsunaga K; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1984 May; 37(5):596-601. PubMed ID: 6376453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
    Recht MI; Douthwaite S; Puglisi JD
    EMBO J; 1999 Jun; 18(11):3133-8. PubMed ID: 10357824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A third kasugamycin resistance locus, ksgC, affecting ribosomal protein S2 in Escherichia coli K-12.
    Yoshikawa M; Okuyama A; Tanaka N
    J Bacteriol; 1975 May; 122(2):796-7. PubMed ID: 1092672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants.
    Hancock RE
    J Antimicrob Chemother; 1981 Oct; 8(4):249-76. PubMed ID: 6795174
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered expression of oligopeptide-binding protein (OppA) and aminoglycoside resistance in laboratory and clinical Escherichia coli strains.
    Acosta MBR; Ferreira RCC; Padilla G; Ferreira LCS; Costa SOP
    J Med Microbiol; 2000 May; 49(5):409-413. PubMed ID: 10798552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.
    Bryan LE; Van Den Elzen HM
    Antimicrob Agents Chemother; 1977 Aug; 12(2):163-77. PubMed ID: 143238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro cross-resistance of kanamycin-resistant mutants of E. coli to other aminoglycoside antibiotics.
    Choi EC; Nishimura T; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Dec; 33(12):1527-31. PubMed ID: 7019176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AcrD of Escherichia coli is an aminoglycoside efflux pump.
    Rosenberg EY; Ma D; Nikaido H
    J Bacteriol; 2000 Mar; 182(6):1754-6. PubMed ID: 10692383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have deoxystreptamine aminoglycoside antibiotics the same binding site on bacterial ribosomes?
    Le Goffic F; Capmau ML; Tangy F; Caminade E
    J Antibiot (Tokyo); 1980 Aug; 33(8):895-9. PubMed ID: 7000739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase.
    Bryan LE; Nicas T; Holloway BW; Crowther C
    Antimicrob Agents Chemother; 1980 Jan; 17(1):71-9. PubMed ID: 6243453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enzymatic adenylylation on dihydrostreptomycin accumulation in Escherichia coli carrying an R-factor: model explaining aminoglycoside resistance by inactivating mechanisms.
    Dickie P; Bryan LE; Pickard MA
    Antimicrob Agents Chemother; 1978 Oct; 14(4):569-80. PubMed ID: 82422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae.
    Levy J; Burns JL; Mendelman PM; Wong K; Mack K; Smith AL
    Antimicrob Agents Chemother; 1986 Mar; 29(3):474-81. PubMed ID: 3487286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of ribosomes of kasugamycin-dependent mutants of Escherichia coli.
    Dabbs ER; Poldermans B; Bakker H; van Knippenberg PH
    FEBS Lett; 1980 Aug; 117(1):164-6. PubMed ID: 6997074
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia.
    Calvopiña K; Dulyayangkul P; Avison MB
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.